(HealthDay News) — Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published online in JAMA Surgery.
USC researchers have found that persistent organic pollutants (POPs)—synthetic toxic chemicals often found in food sources and stored in body fat — are associated with long term higher blood pressure ...
A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...
For those with kidney failure, the wait for a new kidney can take years. There just are not enough organs from deceased ...